Responsible Use of Opioids

Inadequate treatment of pain and abuse of prescription pain medications are both serious public health problems that are increasingly at odds in our society. Pain affects millions of Americans each year. Pain medications can help provide relief from pain. Unfortunately, misuse and abuse of pain medications can lead to tragic consequences, including addiction, overdose, and death.

For many years, Purdue has been an industry leader in the fight against opioid abuse and diversion.

ER/LA Opioid Analgesics REMS

The U.S. Food and Drug Administration (FDA) has mandated that extended-release and long-acting (ER/LA) opioid analgesics have a Risk Evaluation and Mitigation Strategy (REMS) to help ensure that the benefits of the drug outweigh its risks. See how Purdue supports REMS for ER/LA opioid analgesics.

Opioids With Abuse-Deterrent Properties

Purdue was the first company to introduce opioid pain medications with abuse-deterrent properties and labeling claims through development of novel formulations and abuse-deterrence studies.

Combating Opioid Abuse

Purdue works with many partners to help curb diversion, misuse, and abuse of prescription opioids while making sure these medicines remain available for appropriate medical use.

Researched Abuse, Diversion, and Addiction-Related Surveillance (RADARS®) System

For many years, Purdue has dedicated vast resources to combating drug abuse from a range of approaches. The RADARS System, just one example, was developed by Purdue in 2001 to collect and analyze data on drug abuse, diversion, and addiction.

In 2006, Purdue transferred ownership to the Denver Health and Hospital Authority (DHHA) to facilitate access to RADARS surveillance data by pharmaceutical firms and government agencies.

Today, the RADARS System is an independent, non-profit operation of the Rocky Mountain Poison and Drug Center (RMPDC), a division of DHHA.

Radars System

The prescription and illicit opioid abuse crisis is a multifaceted public health challenge, and as a manufacturer of prescription opioids, we have a responsibility to join the fight. At Purdue we are committed to lead our industry in helping address our nation's prescription and illicit opioid abuse crisis.

There is more to come – as we continue to work with partners and experts to deliver solutions. Below you will find additional information about our efforts.

Read our open letter about the opioid crisis.